RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $11,960,000 | -9.7% | 4,000,000 | -20.0% | 2.89% | -1.8% |
Q4 2021 | $13,250,000 | +84.4% | 5,000,000 | +152.5% | 2.94% | +76.0% |
Q3 2021 | $7,187,000 | +10.4% | 1,980,000 | +32.0% | 1.67% | +22.5% |
Q2 2021 | $6,510,000 | -32.5% | 1,500,000 | -56.0% | 1.37% | +2.2% |
Q2 2018 | $9,644,000 | -100.0% | 3,407,840 | -60.3% | 1.34% | -70.4% |
Q1 2018 | $30,371,000,000 | +99125.7% | 8,579,454 | +8.8% | 4.51% | -13.7% |
Q4 2017 | $30,608,000 | +32.3% | 7,888,581 | -13.4% | 5.22% | +16.1% |
Q3 2017 | $23,128,000 | -7.0% | 9,105,691 | 0.0% | 4.50% | +1.0% |
Q2 2017 | $24,859,000 | -17.5% | 9,105,691 | 0.0% | 4.45% | -25.6% |
Q1 2017 | $30,140,000 | +26810.7% | 9,105,691 | +18111.4% | 5.99% | +18606.2% |
Q2 2016 | $112,000 | -65.9% | 50,000 | -68.3% | 0.03% | -72.9% |
Q1 2016 | $328,000 | – | 157,872 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |